학술논문
ONCE DAILY NARLAPREVIR (NVR; SCH 900518) AND RITONAVIR (RTV) IN COMBINATION WITH PEGINTERFERON ALFA-2B/RIBAVIRIN (PR) FOR 12 WEEKS PLUS 12 WEEKS PR IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPE 1 (G1): SVR RESULTS FROM NEXT-1, A PHASE 2 STUDY
Document Type
Journal
Author
Vierling, John M.; Poordad, F. Fred; Lawitz, Eric; Ghalib, Reem H.; Lee, William M.; Ravendhran, Natarajan; Galati, Joseph S.; Bacon, Bruce R.; Flamm, Steven L.; Balart, Luis A.; Freilich, Bradley; Schiff, Eugene R.; Jacobson, Ira M.; Kwo, Paul Y.; Gordon, Stuart C.; Sulkowski, Mark S.; Jiang, Ruiyun; Boparai, Navdeep; Chaudhri, Eirum I.; Treitel, Michelle A.; Hughes, Eric A.; Brass, Clifford A.; Albrecht, Janice K.
Source
Subject
Language
English
ISSN
02709139